News from eli lilly and company A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

06:45 ET Welldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lilly's connected insulin solutions

Welldoc, Inc., and Eli Lilly and Company (NYSE: LLY) announced today a collaboration and licensing agreement to integrate Welldoc's software into...

Feb 24, 2021, 15:00 ET Lilly to Participate in Cowen Health Care Conference

Eli Lilly and Company (NYSE: LLY) will participate in the Cowen and Company 41st Annual Health Care Conference on Thursday, March 4, 2021. Daniel...

Feb 17, 2021, 06:45 ET Tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes in two phase 3 trials from Lilly's SURPASS program

Tirzepatide led to significant A1C and body weight reductions from baseline in adults with type 2 diabetes in Eli Lilly and Company's (NYSE: LLY)...

Feb 17, 2021, 06:30 ET Kimberly H. Johnson Elected to Lilly Board of Directors

The board of directors of Eli Lilly and Company (NYSE: LLY) has elected Kimberly H. Johnson as a new member, effective February 16, 2021. As a member ...

Feb 11, 2021, 16:30 ET Lilly To Participate in SVB Leerink Global Healthcare Conference

Eli Lilly and Company (NYSE:LLY) will participate in the 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24, 2021. Ilya...

Feb 09, 2021, 19:29 ET Lilly's bamlanivimab (LY-CoV555) administered with etesevimab (LY-CoV016) receives FDA emergency use authorization for COVID-19

The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for investigational bamlanivimab (LY-CoV555) 700 mg and...

Feb 09, 2021, 07:00 ET Lilly Appoints Anat Ashkenazi Chief Financial Officer

Eli Lilly and Company (NYSE: LLY) today announced the appointment of Anat Ashkenazi as senior vice president and chief financial officer. Ms....

Feb 04, 2021, 16:30 ET Lilly Announces Webcast to Provide Alzheimer's Disease Update at AD/PD Conference

Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Monday, March 15, 2021 to provide an update on its Alzheimer's disease program and...

Feb 03, 2021, 17:16 ET Lilly to Participate in Guggenheim Healthcare Talks 2021 Oncology Day

Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Healthcare Talks 2021 Oncology Day on Friday, February 12, 2021. Anne White,...

Feb 01, 2021, 07:30 ET Lilly Partners with Area Health Systems to Help Enable Access to Important Antibody Infusion Therapies for COVID-19 Patients

Eli Lilly and Company (NYSE: LLY) has partnered with local health systems to launch dedicated infusion center locations serving central, northern,...

Jan 29, 2021, 06:20 ET Lilly Reports Strong Fourth-Quarter and Full-Year 2020 Financial Results

Eli Lilly and Company (NYSE: LLY) today announced financial results for the fourth quarter and full year of 2020. $ in millions, except per share...
Lilly, Life for a Child and Beyond Type 1 advance partnership to improve diabetes care in resource-limited countries

Jan 28, 2021, 08:00 ET Lilly, Life for a Child and Beyond Type 1 advance partnership to improve diabetes care in resource-limited countries

To address inequity in access to quality diabetes care for many children and young adults around the world, Eli Lilly and Company (NYSE: LLY) and...

Jan 28, 2021, 06:34 ET Lilly and Asahi Kasei Pharma Announce License Agreement for Chronic Pain Drug Candidate

Eli Lilly and Company (NYSE: LLY) and Asahi Kasei Pharma Corporation today announced a license agreement whereby Lilly will acquire the exclusive...

Jan 27, 2021, 06:45 ET Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19

Eli Lilly and Company (NYSE: LLY), Vir Biotechnology, Inc. (NASDAQ: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today announced a collaboration to...

Jan 26, 2021, 06:45 ET New data show treatment with Lilly's neutralizing antibodies bamlanivimab (LY-CoV555) and etesevimab (LY-CoV016) together reduced risk of COVID-19 hospitalizations and death by 70 percent

Bamlanivimab (LY-CoV555) 2800 mg and etesevimab (LY-CoV016) 2800 mg together significantly reduced COVID-19-related hospitalizations and deaths...

Jan 22, 2021, 08:55 ET Lilly Completes Acquisition of Prevail Therapeutics

Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Prevail Therapeutics Inc. (NASDAQ: PRVL). The...

Jan 21, 2021, 08:00 ET Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial, reducing risk by up to 80 percent for residents

Bamlanivimab (LY-CoV555) significantly reduced the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities,...

Jan 19, 2021, 06:30 ET Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies

Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and Merus N.V. (NASDAQ: MRUS), a clinical-stage...

Jan 15, 2021, 17:02 ET Lilly Confirms Date and Conference Call for Fourth-Quarter 2020 Financial Results Announcement

Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2020 financial results on Friday, January 29, 2021. Lilly will also...

Jan 15, 2021, 06:45 ET Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund

Eli Lilly and Company (NYSE: LLY) today announced a $30 million limited partner investment in Unseen Capital Health Fund LP, a newly-formed venture...

Jan 14, 2021, 06:45 ET Gabrielle Sulzberger Elected to Lilly Board of Directors

The board of directors of Eli Lilly and Company (NYSE: LLY) has elected Gabrielle Sulzberger as a new member, effective January 25, 2021. As a member ...

Jan 11, 2021, 08:00 ET US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction

The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Jardiance® (empagliflozin) which is being...

Jan 11, 2021, 06:30 ET Lilly's Donanemab Slows Clinical Decline of Alzheimer's Disease in Positive Phase 2 Trial

Donanemab, an investigational antibody that targets a modified form of beta amyloid called N3pG, showed significant slowing of decline in a composite ...

Jan 04, 2021, 15:30 ET Lilly to Participate in J.P. Morgan Healthcare Conference

Eli Lilly and Company (NYSE:LLY) will participate in the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021. David A. Ricks,...

Dec 18, 2020, 17:00 ET Lilly to begin pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19 in New Mexico

Eli Lilly and Company (NYSE: LLY) today announced plans to begin a new pragmatic study of bamlanivimab (LY-CoV555) in high-risk patients with...